Skip to main content
Erschienen in: Endocrine 2/2014

01.03.2014 | Review

Muscle–bone interactions: basic and clinical aspects

Erschienen in: Endocrine | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Muscle and bone are anatomically and functionally closely connected. The traditional concept that skeletal muscles serve to load bone and transform skeletal segments into a system of levers has been further refined into the mechanostat theory, according to which striated muscle is essential for bone development and maintenance, modelling and remodelling. Besides biomechanical function, skeletal muscle and bone are endocrine organs able to secrete factors capable of modulating biological function within their microenvironment, in nearby tissues or in distant organs. The endocrine properties of muscle and bone may serve to sense and transduce biomechanical signals such as loading, unloading or exercise, or systemic hormonal stimuli into biochemical signals. Nonetheless, given the close anatomical relationship between skeletal muscle and bone, paracrine interactions particularly at the periosteal interface can be hypothesized. These mechanisms can assume particular importance during bone and muscle healing after musculoskeletal injury. Basic studies in vitro and in rodents have helped to dissect the multiple influences of skeletal muscle on bone and/or expression of inside-organ metabolism and have served to explain clinical observations linking muscle-to-bone quality. Recent evidences pinpoint that also bone tissue is able to modulate directly or indirectly skeletal muscle metabolism, thus empowering the crosstalk hypothesis to be further tested in humans in vivo.
Literatur
1.
Zurück zum Zitat D.B. Burr, A.G. Robling, C.H. Turner, Effects of biomechanical stress on bones in animals. Bone 30, 781–786 (2002)PubMed D.B. Burr, A.G. Robling, C.H. Turner, Effects of biomechanical stress on bones in animals. Bone 30, 781–786 (2002)PubMed
2.
Zurück zum Zitat Y.X. Qin, H. Lam, S. Ferreri, C. Rubin, Dynamic skeletal muscle stimulation and its potential in bone adaptation. J. Musculoskelet. Neuronal Interact. 10, 12–24 (2010)PubMed Y.X. Qin, H. Lam, S. Ferreri, C. Rubin, Dynamic skeletal muscle stimulation and its potential in bone adaptation. J. Musculoskelet. Neuronal Interact. 10, 12–24 (2010)PubMed
3.
Zurück zum Zitat D.J. DiGirolamo, T.L. Clemens, S. Kousteni, The skeleton as an endocrine organ. Nat. Rev. Rheumatol. 8, 674–683 (2012)PubMed D.J. DiGirolamo, T.L. Clemens, S. Kousteni, The skeleton as an endocrine organ. Nat. Rev. Rheumatol. 8, 674–683 (2012)PubMed
4.
Zurück zum Zitat G. Karsenty, F. Oury, Biology without walls: the novel endocrinology of bone. Ann. Rev. Physiol. 74, 87–105 (2012) G. Karsenty, F. Oury, Biology without walls: the novel endocrinology of bone. Ann. Rev. Physiol. 74, 87–105 (2012)
5.
Zurück zum Zitat S.C. Forbes, J.P. Little, D.G. Candow, Exercise and nutritional interventions for improving aging muscle health. Endocrine 42, 29–38 (2012)PubMed S.C. Forbes, J.P. Little, D.G. Candow, Exercise and nutritional interventions for improving aging muscle health. Endocrine 42, 29–38 (2012)PubMed
6.
Zurück zum Zitat B.K. Pedersen, Muscles and their myokines. J. Exp. Biol. 214, 337–346 (2011)PubMed B.K. Pedersen, Muscles and their myokines. J. Exp. Biol. 214, 337–346 (2011)PubMed
7.
Zurück zum Zitat F. Norheim, T. Raastad, B. Thiede, A.C. Rustan, C.A. Drevon, F. Haugen, Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training. Am. J. Physiol. Endocrinol. Metab. 301, E1013–E1021 (2011)PubMed F. Norheim, T. Raastad, B. Thiede, A.C. Rustan, C.A. Drevon, F. Haugen, Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training. Am. J. Physiol. Endocrinol. Metab. 301, E1013–E1021 (2011)PubMed
8.
Zurück zum Zitat S. Bortoluzzi, P. Scannapieco, A. Cestaro, G.A. Danieli, S. Schiaffino, Computational reconstruction of the human skeletal muscle secretome. Proteins 62, 776–792 (2006)PubMed S. Bortoluzzi, P. Scannapieco, A. Cestaro, G.A. Danieli, S. Schiaffino, Computational reconstruction of the human skeletal muscle secretome. Proteins 62, 776–792 (2006)PubMed
9.
Zurück zum Zitat B.K. Pedersen, M.A. Febbraio, Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8, 457–465 (2012)PubMed B.K. Pedersen, M.A. Febbraio, Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8, 457–465 (2012)PubMed
11.
Zurück zum Zitat E. Seeman, J.L. Hopper, N.R. Young, C. Formica, P. Goss, C. Tsalamandris, Do genetic factors explain associations between muscle strength, lean mass, and bone density? a twin study. Am. J. Physiol. 270, E320–E327 (1996)PubMed E. Seeman, J.L. Hopper, N.R. Young, C. Formica, P. Goss, C. Tsalamandris, Do genetic factors explain associations between muscle strength, lean mass, and bone density? a twin study. Am. J. Physiol. 270, E320–E327 (1996)PubMed
12.
Zurück zum Zitat D. Karasik, D.P. Kiel, Evidence for pleiotropic factors in genetics of the musculoskeletal system. Bone 46, 1226–1237 (2010)PubMed D. Karasik, D.P. Kiel, Evidence for pleiotropic factors in genetics of the musculoskeletal system. Bone 46, 1226–1237 (2010)PubMed
13.
Zurück zum Zitat D. Karasik, C.L. Cheung, Y. Zhou, L.A. Cupples, D.P. Kiel, S. Demissie, Genome-wide association of an integrated osteoporosis-related phenotype: is there evidence for pleiotropic genes? J. Bone Miner. Res. 27, 319–330 (2012)PubMedCentralPubMed D. Karasik, C.L. Cheung, Y. Zhou, L.A. Cupples, D.P. Kiel, S. Demissie, Genome-wide association of an integrated osteoporosis-related phenotype: is there evidence for pleiotropic genes? J. Bone Miner. Res. 27, 319–330 (2012)PubMedCentralPubMed
14.
Zurück zum Zitat C. Cooper, W. Dere, W. Evans, J.A. Kanis, R. Rizzoli, A.A. Sayer, C.C. Sieber, J.M. Kaufman, G. Abellan van Kan, S. Boonen, J. Adachi, B. Mitlak, Y. Tsouderos, Y. Rolland, J.Y. Reginster, Frailty and sarcopenia: definitions and outcome parameters. Osteoporos. Int. 23, 1839–1848 (2012)PubMed C. Cooper, W. Dere, W. Evans, J.A. Kanis, R. Rizzoli, A.A. Sayer, C.C. Sieber, J.M. Kaufman, G. Abellan van Kan, S. Boonen, J. Adachi, B. Mitlak, Y. Tsouderos, Y. Rolland, J.Y. Reginster, Frailty and sarcopenia: definitions and outcome parameters. Osteoporos. Int. 23, 1839–1848 (2012)PubMed
15.
16.
Zurück zum Zitat A. Tajar, I.T. Huhtaniemi, T.W. O’Neill, J.D. Finn, S.R. Pye, D.M. Lee, G. Bartfai, S. Boonen, F.F. Casanueva, G. Forti, A. Giwercman, T.S. Han, K. Kula, F. Labrie, M.E. Lean, N. Pendleton, M. Punab, D. Vanderschueren, F.C. Wu, EMAS Group, Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J. Clin. Endocrinol. Metab. 97, 1508–1516 (2012)PubMed A. Tajar, I.T. Huhtaniemi, T.W. O’Neill, J.D. Finn, S.R. Pye, D.M. Lee, G. Bartfai, S. Boonen, F.F. Casanueva, G. Forti, A. Giwercman, T.S. Han, K. Kula, F. Labrie, M.E. Lean, N. Pendleton, M. Punab, D. Vanderschueren, F.C. Wu, EMAS Group, Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J. Clin. Endocrinol. Metab. 97, 1508–1516 (2012)PubMed
17.
Zurück zum Zitat M. Spitzer, G. Huang, S. Basaria, T.G. Travison, S. Bhasin, Risks and benefits of testosterone therapy in older men. Nat. Rev. Endocrinol. 9, 414–424 (2013)PubMed M. Spitzer, G. Huang, S. Basaria, T.G. Travison, S. Bhasin, Risks and benefits of testosterone therapy in older men. Nat. Rev. Endocrinol. 9, 414–424 (2013)PubMed
18.
Zurück zum Zitat P. Lips, N.M. van Schoor, The effect of vitamin D on bone and osteoporosis. Best Pract. Res. Clin. Endocrinol. Metab. 25, 585–591 (2011)PubMed P. Lips, N.M. van Schoor, The effect of vitamin D on bone and osteoporosis. Best Pract. Res. Clin. Endocrinol. Metab. 25, 585–591 (2011)PubMed
19.
Zurück zum Zitat H.A. Bischoff-Ferrari, Relevance of vitamin D in muscle health. Rev. Endocr. Metab. Disord. 13, 71–77 (2012)PubMed H.A. Bischoff-Ferrari, Relevance of vitamin D in muscle health. Rev. Endocr. Metab. Disord. 13, 71–77 (2012)PubMed
20.
Zurück zum Zitat L. Ceglia, S.S. Harris, Vitamin D and its role in skeletal muscle. Calcif. Tissue Int. 92, 151–162 (2013)PubMed L. Ceglia, S.S. Harris, Vitamin D and its role in skeletal muscle. Calcif. Tissue Int. 92, 151–162 (2013)PubMed
21.
Zurück zum Zitat C.M. Girgis, R.J. Clifton-Bligh, M.W. Hamrick, M.F. Holick, J.E. Gunton, The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr. Rev. 34, 33–83 (2013)PubMed C.M. Girgis, R.J. Clifton-Bligh, M.W. Hamrick, M.F. Holick, J.E. Gunton, The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr. Rev. 34, 33–83 (2013)PubMed
22.
Zurück zum Zitat L. Schubert, H.F. DeLuca, Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch. Biochem. Biophys. 500, 157–161 (2010)PubMed L. Schubert, H.F. DeLuca, Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch. Biochem. Biophys. 500, 157–161 (2010)PubMed
23.
Zurück zum Zitat H.F. Wang, Y. DeLuca, Is the vitamin D receptor found in muscle? Endocrinology 152, 354–363 (2011)PubMed H.F. Wang, Y. DeLuca, Is the vitamin D receptor found in muscle? Endocrinology 152, 354–363 (2011)PubMed
24.
Zurück zum Zitat K.B. Hagen, H. Dagfinrud, R.H. Moe, N. Østerås, I. Kjeken, M. Grotle, G. Smedslund, Exercise therapy for bone and muscle health: an overview of systematic reviews. BMC Med. 10, 167 (2012)PubMedCentralPubMed K.B. Hagen, H. Dagfinrud, R.H. Moe, N. Østerås, I. Kjeken, M. Grotle, G. Smedslund, Exercise therapy for bone and muscle health: an overview of systematic reviews. BMC Med. 10, 167 (2012)PubMedCentralPubMed
25.
Zurück zum Zitat A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535–559 (2008)PubMed A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535–559 (2008)PubMed
26.
27.
Zurück zum Zitat S. Perrini, L. Laviola, M.C. Carreira, A. Cignarelli, A. Natalicchio, F. Giorgino, The GH/IGF1 axis and signalling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J. Endocrinol. 205, 201–210 (2010)PubMed S. Perrini, L. Laviola, M.C. Carreira, A. Cignarelli, A. Natalicchio, F. Giorgino, The GH/IGF1 axis and signalling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J. Endocrinol. 205, 201–210 (2010)PubMed
28.
Zurück zum Zitat J.K. Park, J.W. Hong, C.O. Kim, S.W. Kim, C.Y. Lim, Y.S. Chung, S.W. Kim, E.J. Lee, Sustained-release recombinant human growth hormone improves body composition and quality of life in adults with somatopause. J. Am. Geriatr. Soc. 59, 944–947 (2011)PubMed J.K. Park, J.W. Hong, C.O. Kim, S.W. Kim, C.Y. Lim, Y.S. Chung, S.W. Kim, E.J. Lee, Sustained-release recombinant human growth hormone improves body composition and quality of life in adults with somatopause. J. Am. Geriatr. Soc. 59, 944–947 (2011)PubMed
29.
Zurück zum Zitat M.D. Mavalli, D.J. Di Girolamo, Y. Fan, R.C. Riddle, K.S. Campbell, T. van Groen, S.J. Frank, M.A. Sperling, K.A. Esser, M.M. Bamman, T.L. Clemens, Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J. Clin. Invest. 120, 4007–4020 (2010)PubMedCentralPubMed M.D. Mavalli, D.J. Di Girolamo, Y. Fan, R.C. Riddle, K.S. Campbell, T. van Groen, S.J. Frank, M.A. Sperling, K.A. Esser, M.M. Bamman, T.L. Clemens, Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J. Clin. Invest. 120, 4007–4020 (2010)PubMedCentralPubMed
31.
Zurück zum Zitat M.A. Bredella, P.K. Fazeli, B. Lecka-Czernik, C.J. Rosen, A. Klibanski, IGFBP-2 is a negative predictor of cold-induced brown fat and bone mineral density in young non-obese women. Bone 53, 336–339 (2013)PubMed M.A. Bredella, P.K. Fazeli, B. Lecka-Czernik, C.J. Rosen, A. Klibanski, IGFBP-2 is a negative predictor of cold-induced brown fat and bone mineral density in young non-obese women. Bone 53, 336–339 (2013)PubMed
32.
Zurück zum Zitat J.N. Farr, N. Charkoudian, J.N. Barnes, D.G. Monroe, L.K. McCready, E.J. Atkinson, S. Amin, L.J. Melton 3rd, M.J. Joyner, S. Khosla, Relationship of sympathetic activity to bone microstructure, turnover, and plasma osteopontin levels in women. J. Clin. Endocrinol. Metab. 97, 4219–4227 (2012)PubMed J.N. Farr, N. Charkoudian, J.N. Barnes, D.G. Monroe, L.K. McCready, E.J. Atkinson, S. Amin, L.J. Melton 3rd, M.J. Joyner, S. Khosla, Relationship of sympathetic activity to bone microstructure, turnover, and plasma osteopontin levels in women. J. Clin. Endocrinol. Metab. 97, 4219–4227 (2012)PubMed
33.
Zurück zum Zitat P. Boström, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, J.C. Lo, K.A. Rasbach, E.A. Boström, J.H. Choi, J.Z. Long, S. Kajimura, M.C. Zingaretti, B.F. Vind, H. Tu, S. Cinti, K. Højlund, S.P. Gygi, B.M. Spiegelman, A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463–468 (2012)PubMedCentralPubMed P. Boström, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, J.C. Lo, K.A. Rasbach, E.A. Boström, J.H. Choi, J.Z. Long, S. Kajimura, M.C. Zingaretti, B.F. Vind, H. Tu, S. Cinti, K. Højlund, S.P. Gygi, B.M. Spiegelman, A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463–468 (2012)PubMedCentralPubMed
34.
Zurück zum Zitat K. Redlich, J.S. Smolen, Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat. Rev. Drug Discov 11, 234–250 (2012)PubMed K. Redlich, J.S. Smolen, Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat. Rev. Drug Discov 11, 234–250 (2012)PubMed
35.
Zurück zum Zitat D.J. Glass, Signaling pathways perturbing muscle mass. Curr. Opin. Clin. Nutr. Metab. Care 13, 225–229 (2010)PubMed D.J. Glass, Signaling pathways perturbing muscle mass. Curr. Opin. Clin. Nutr. Metab. Care 13, 225–229 (2010)PubMed
36.
Zurück zum Zitat W.S. Lee, W.H. Cheung, L. Qin, N. Tang, K.S. Leung, Age-associated decrease of type IIA/B human skeletal muscle fibers. Clin. Orthop. Relat. Res. 450, 231–237 (2006)PubMed W.S. Lee, W.H. Cheung, L. Qin, N. Tang, K.S. Leung, Age-associated decrease of type IIA/B human skeletal muscle fibers. Clin. Orthop. Relat. Res. 450, 231–237 (2006)PubMed
37.
Zurück zum Zitat A.J. Cruz-Jentoft, J.P. Baeyens, J.M. Bauer, Y. Boirie, T. Cederholm, F. Landi, F.C. Martin, J.P. Michel, Y. Rolland, S.M. Schneider, E. Topinková, M. Vandewoude, M. Zamboni, Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age ageing 39, 412–423 (2010)PubMed A.J. Cruz-Jentoft, J.P. Baeyens, J.M. Bauer, Y. Boirie, T. Cederholm, F. Landi, F.C. Martin, J.P. Michel, Y. Rolland, S.M. Schneider, E. Topinková, M. Vandewoude, M. Zamboni, Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age ageing 39, 412–423 (2010)PubMed
38.
Zurück zum Zitat R.A. Fielding, B. Vellas, W.J. Evans, S. Bhasin, J.E. Morley, A.B. Newman, G. Abellan van Kan, S. Andrieu, J. Bauer, D. Breuille, T. Cederholm, J. Chandler, C. De Meynard, L. Donini, T. Harris, A. Kannt, Keime, F. Guibert, G. Onder, D. Papanicolaou, Y. Rolland, D. Rooks, C. Sieber, E. Souhami, S. Verlaan, M. Zamboni, Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 12, 249–256 (2011)PubMed R.A. Fielding, B. Vellas, W.J. Evans, S. Bhasin, J.E. Morley, A.B. Newman, G. Abellan van Kan, S. Andrieu, J. Bauer, D. Breuille, T. Cederholm, J. Chandler, C. De Meynard, L. Donini, T. Harris, A. Kannt, Keime, F. Guibert, G. Onder, D. Papanicolaou, Y. Rolland, D. Rooks, C. Sieber, E. Souhami, S. Verlaan, M. Zamboni, Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 12, 249–256 (2011)PubMed
40.
Zurück zum Zitat E. Anliker, M. Toigo, Functional assessment of the muscle-bone unit in the lower leg. J. Musculoskelet. Neuronal Interact. 12, 46–55 (2012)PubMed E. Anliker, M. Toigo, Functional assessment of the muscle-bone unit in the lower leg. J. Musculoskelet. Neuronal Interact. 12, 46–55 (2012)PubMed
41.
Zurück zum Zitat T. Montalcini, V. Migliaccio, F. Yvelise, S. Rotundo, E. Mazza, A. Liberato, A. Pujia, Reference values for handgrip strength in young people of both sexes. Endocrine 43, 342–345 (2013)PubMed T. Montalcini, V. Migliaccio, F. Yvelise, S. Rotundo, E. Mazza, A. Liberato, A. Pujia, Reference values for handgrip strength in young people of both sexes. Endocrine 43, 342–345 (2013)PubMed
42.
Zurück zum Zitat H.H. Bolotin, A new perspective on the causal influence of soft tissue composition on DXA-measured in vivo bone mineral density. J. Bone Miner. Res. 13, 1739–1746 (1998)PubMed H.H. Bolotin, A new perspective on the causal influence of soft tissue composition on DXA-measured in vivo bone mineral density. J. Bone Miner. Res. 13, 1739–1746 (1998)PubMed
43.
Zurück zum Zitat B.S. Zemel, Quantitative computed tomography and computed tomography in children. Curr. Osteoporos. Rep. 9, 284–290 (2011)PubMed B.S. Zemel, Quantitative computed tomography and computed tomography in children. Curr. Osteoporos. Rep. 9, 284–290 (2011)PubMed
44.
Zurück zum Zitat A.M. Cheung, J.D. Adachi, D.A. Hanley, D.L. Kendler, K.S. Davison, R. Josse, J.P. Brown, L.G. Ste-Marie, R. Kremer, M.C. Erlandson, L. Dian, A.J. Burghardt, S.K. Boyd, High-Resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group. Curr. Osteoporos. Rep. 11(2), 136–146 (2013)PubMedCentralPubMed A.M. Cheung, J.D. Adachi, D.A. Hanley, D.L. Kendler, K.S. Davison, R. Josse, J.P. Brown, L.G. Ste-Marie, R. Kremer, M.C. Erlandson, L. Dian, A.J. Burghardt, S.K. Boyd, High-Resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group. Curr. Osteoporos. Rep. 11(2), 136–146 (2013)PubMedCentralPubMed
45.
Zurück zum Zitat E. Schoenau, C.M. Neu, B. Beck, F. Manz, F. Rauch, Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit. J. Bone Miner. Res. 17, 1095–1101 (2002)PubMed E. Schoenau, C.M. Neu, B. Beck, F. Manz, F. Rauch, Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit. J. Bone Miner. Res. 17, 1095–1101 (2002)PubMed
46.
Zurück zum Zitat K.L. Butner, K.W. Creamer, S.M. Nickols-Richardson, S.F. Clark, W.K. Ramp, W.G. Herbert, Fat and muscle indices assessed by pQCT: relationships with physical activity and type 2 diabetes risk. J. Clin. Densitom. 15, 355–361 (2012)PubMed K.L. Butner, K.W. Creamer, S.M. Nickols-Richardson, S.F. Clark, W.K. Ramp, W.G. Herbert, Fat and muscle indices assessed by pQCT: relationships with physical activity and type 2 diabetes risk. J. Clin. Densitom. 15, 355–361 (2012)PubMed
47.
Zurück zum Zitat S. Coupaud, L.P. Jack, K.J. Hunt, K.J. Hunt, D.B. Allan, Muscle and bone adaptations after treadmill training in incomplete spinal cord injury: a case study using peripheral quantitative computed tomography. J. Musculoskelet. Neuronal Interact. 9, 288–297 (2009)PubMed S. Coupaud, L.P. Jack, K.J. Hunt, K.J. Hunt, D.B. Allan, Muscle and bone adaptations after treadmill training in incomplete spinal cord injury: a case study using peripheral quantitative computed tomography. J. Musculoskelet. Neuronal Interact. 9, 288–297 (2009)PubMed
48.
Zurück zum Zitat N. Stolzenberg, D.L. Belavy, G. Beller, G. Armbrecht, J. Semler, D. Felsenberg, Bone strength and density via pQCT in post-menopausal osteopenic women after 9 months resistive exercise with whole body vibration or proprioceptive exercise. J. Musculoskelet. Neuronal Interact. 13, 66–76 (2013)PubMed N. Stolzenberg, D.L. Belavy, G. Beller, G. Armbrecht, J. Semler, D. Felsenberg, Bone strength and density via pQCT in post-menopausal osteopenic women after 9 months resistive exercise with whole body vibration or proprioceptive exercise. J. Musculoskelet. Neuronal Interact. 13, 66–76 (2013)PubMed
49.
Zurück zum Zitat A.A. Sayer, E.M. Dennison, H.E. Syddall, K. Jameson, H.J. Martin, C. Cooper, The developmental origins of sarcopenia: using peripheral quantitative computed tomography to assess muscle size in older people. J. Gerontol. A 63, 835–840 (2008) A.A. Sayer, E.M. Dennison, H.E. Syddall, K. Jameson, H.J. Martin, C. Cooper, The developmental origins of sarcopenia: using peripheral quantitative computed tomography to assess muscle size in older people. J. Gerontol. A 63, 835–840 (2008)
50.
Zurück zum Zitat J.N. Farr, J.L. Funk, Z. Chen, J.R. Lisse, R.M. Blew, V.R. Lee, M. Laudermilk, T.G. Lohman, S.B. Going, Skeletal muscle fat content is inversely associated with bone strength in young girls. J. Bone Miner. Res. 26, 2217–2225 (2011)PubMed J.N. Farr, J.L. Funk, Z. Chen, J.R. Lisse, R.M. Blew, V.R. Lee, M. Laudermilk, T.G. Lohman, S.B. Going, Skeletal muscle fat content is inversely associated with bone strength in young girls. J. Bone Miner. Res. 26, 2217–2225 (2011)PubMed
51.
Zurück zum Zitat A.K. Wong, A. Bhargava, K. Beattie, K. Beattie, C.L. Gordon, L. Pickard, C.E. Webber, A. Papaioannou, J. Adachi, J. Adachi, Muscle density, a surrogate of intermuscular adiposity derived from pQCT, is an independent correlate of fractures in women. J. Bone Miner. Res. 26(Suppl 1), 2341–2357 (2011) A.K. Wong, A. Bhargava, K. Beattie, K. Beattie, C.L. Gordon, L. Pickard, C.E. Webber, A. Papaioannou, J. Adachi, J. Adachi, Muscle density, a surrogate of intermuscular adiposity derived from pQCT, is an independent correlate of fractures in women. J. Bone Miner. Res. 26(Suppl 1), 2341–2357 (2011)
52.
Zurück zum Zitat T. Lang, J.A. Cauley, F. Tylavsky, D. Bauer, S. Cummings, T.B. Harris, Health ABC Study, Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: the health, aging, and body composition study. J. Bone Miner. Res. 25, 513–519 (2010)PubMed T. Lang, J.A. Cauley, F. Tylavsky, D. Bauer, S. Cummings, T.B. Harris, Health ABC Study, Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: the health, aging, and body composition study. J. Bone Miner. Res. 25, 513–519 (2010)PubMed
53.
Zurück zum Zitat K. Deere, A. Sayers, H. Viljakainen, D. Lawlor, N. Sattar, J. Kemp, W. Fraser, J. Tobias, Distinct relationships of intramuscular and subcutaneous fat with cortical bone: findings from a cross-sectional study of young adult males and females. J. Clin. Endocrinol. Metab. 98(6), E1041 (2013)PubMed K. Deere, A. Sayers, H. Viljakainen, D. Lawlor, N. Sattar, J. Kemp, W. Fraser, J. Tobias, Distinct relationships of intramuscular and subcutaneous fat with cortical bone: findings from a cross-sectional study of young adult males and females. J. Clin. Endocrinol. Metab. 98(6), E1041 (2013)PubMed
54.
Zurück zum Zitat J.F. Baker, M. Davis, R. Alexander, B.S. Zemel, S. Mostoufi-Moab, J. Shults, M. Sulik, D.J. Schiferl, M.B. Leonard, Associations between body composition and bone density and structure in men and women across the adult age spectrum. Bone 53, 34–41 (2013)PubMed J.F. Baker, M. Davis, R. Alexander, B.S. Zemel, S. Mostoufi-Moab, J. Shults, M. Sulik, D.J. Schiferl, M.B. Leonard, Associations between body composition and bone density and structure in men and women across the adult age spectrum. Bone 53, 34–41 (2013)PubMed
55.
Zurück zum Zitat J.L. Ferretti, R.F. Capozza, G.R. Cointry, S.L. García, H. Plotkin, M.L. Alvarez Filgueira, J.R. Zanchetta, Gender-related differences in the relationship between densitometric values of whole-body bone mineral content and lean body mass in humans between 2 and 87 years of age. Bone 22, 683–690 (1998)PubMed J.L. Ferretti, R.F. Capozza, G.R. Cointry, S.L. García, H. Plotkin, M.L. Alvarez Filgueira, J.R. Zanchetta, Gender-related differences in the relationship between densitometric values of whole-body bone mineral content and lean body mass in humans between 2 and 87 years of age. Bone 22, 683–690 (1998)PubMed
56.
Zurück zum Zitat H. Zhang, X. Chai, S. Li, Z. Zhang, L. Yuan, H. Xie, H. Zhou, X. Wu, Z. Sheng, E. Liao, Age-related changes in body composition and their relationship with bone mineral density decreasing rates in central south Chinese postmenopausal women. Endocrine 43, 643–650 (2013)PubMed H. Zhang, X. Chai, S. Li, Z. Zhang, L. Yuan, H. Xie, H. Zhou, X. Wu, Z. Sheng, E. Liao, Age-related changes in body composition and their relationship with bone mineral density decreasing rates in central south Chinese postmenopausal women. Endocrine 43, 643–650 (2013)PubMed
57.
Zurück zum Zitat N.K. Lebrasseur, S.J. Achenbach, L.J. Melton 3rd, S. Amin, S. Khosla, Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men. J. Bone Miner. Res. 27, 2159–2169 (2012)PubMedCentralPubMed N.K. Lebrasseur, S.J. Achenbach, L.J. Melton 3rd, S. Amin, S. Khosla, Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men. J. Bone Miner. Res. 27, 2159–2169 (2012)PubMedCentralPubMed
58.
Zurück zum Zitat H.M. Frost, Muscle strength, bone mass, and age-related bone loss. J. Bone Miner. Res. 12, 1547–1551 (1997) H.M. Frost, Muscle strength, bone mass, and age-related bone loss. J. Bone Miner. Res. 12, 1547–1551 (1997)
59.
Zurück zum Zitat E. Schoenau, From mechanostat theory to development of the “functional muscle-bone-unit”. J. Musculoskelet. Neuronal Interact. 5, 232–238 (2005)PubMed E. Schoenau, From mechanostat theory to development of the “functional muscle-bone-unit”. J. Musculoskelet. Neuronal Interact. 5, 232–238 (2005)PubMed
60.
Zurück zum Zitat L.F. Bonewald, The amazing osteocyte. J. Bone Miner. Res. 26, 229–238 (2011)PubMed L.F. Bonewald, The amazing osteocyte. J. Bone Miner. Res. 26, 229–238 (2011)PubMed
61.
Zurück zum Zitat C. Rubin, A.S. Turner, S. Bain, C. Mallinckrodt, K. McLeod, Anabolism: low mechanical signals strengthen long bones. Nature 412, 603–604 (2001)PubMed C. Rubin, A.S. Turner, S. Bain, C. Mallinckrodt, K. McLeod, Anabolism: low mechanical signals strengthen long bones. Nature 412, 603–604 (2001)PubMed
62.
Zurück zum Zitat F. Rauch, D.A. Bailey, A. Baxter-Jones, R. Mirwald, R. Faulkner, The ‘muscle-bone unit’ during the pubertal growth spurt. Bone 34, 771–775 (2004)PubMed F. Rauch, D.A. Bailey, A. Baxter-Jones, R. Mirwald, R. Faulkner, The ‘muscle-bone unit’ during the pubertal growth spurt. Bone 34, 771–775 (2004)PubMed
63.
Zurück zum Zitat O. Fricke, R. Beccard, O. Semler, E. Schoenau, Analyses of muscular mass and function: the impact on bone mineral density and peak muscle mass. Pediatr. Nephrol. 25, 2393–2400 (2010)PubMed O. Fricke, R. Beccard, O. Semler, E. Schoenau, Analyses of muscular mass and function: the impact on bone mineral density and peak muscle mass. Pediatr. Nephrol. 25, 2393–2400 (2010)PubMed
64.
Zurück zum Zitat L. Xu, Q. Wang, Q. Wang, A. Lyytikäinen, T. Mikkola, E. Völgyi, S. Cheng, P. Wiklund, E. Munukka, P. Nicholson, M. Alén, S. Cheng, Concerted actions of insulin-like growth factor 1, testosterone, and estradiol on peripubertal bone growth: a 7-year longitudinal study. J. Bone Miner. Res. 26, 2204–2211 (2011)PubMed L. Xu, Q. Wang, Q. Wang, A. Lyytikäinen, T. Mikkola, E. Völgyi, S. Cheng, P. Wiklund, E. Munukka, P. Nicholson, M. Alén, S. Cheng, Concerted actions of insulin-like growth factor 1, testosterone, and estradiol on peripubertal bone growth: a 7-year longitudinal study. J. Bone Miner. Res. 26, 2204–2211 (2011)PubMed
65.
Zurück zum Zitat G.L. Klein, L.A. Fitzpatrick, C.B. Langman, T.J. Beck, T.O. Carpenter, V. Gilsanz, I.A. Holm, M.B. Leonard, B.L. Specker, ASBMR Group, The state of pediatric bone: summary of the ASBMR pediatric bone initiative. J. Bone Miner. Res. 20, 2075–2081 (2005)PubMed G.L. Klein, L.A. Fitzpatrick, C.B. Langman, T.J. Beck, T.O. Carpenter, V. Gilsanz, I.A. Holm, M.B. Leonard, B.L. Specker, ASBMR Group, The state of pediatric bone: summary of the ASBMR pediatric bone initiative. J. Bone Miner. Res. 20, 2075–2081 (2005)PubMed
66.
Zurück zum Zitat M.B. Leonard, A. Elmi, S. Mostoufi-Moab, J. Shults, J.M. Burnham, M. Thayu, L. Kibe, R.J. Wetzsteon, B.S. Zemel, Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults. J. Clin. Endocrinol. Metab. 95, 1681–1689 (2010)PubMed M.B. Leonard, A. Elmi, S. Mostoufi-Moab, J. Shults, J.M. Burnham, M. Thayu, L. Kibe, R.J. Wetzsteon, B.S. Zemel, Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults. J. Clin. Endocrinol. Metab. 95, 1681–1689 (2010)PubMed
67.
Zurück zum Zitat J.M. Burnham, J. Shults, H. Sembhi, B.S. Zemel, M.B. Leonard, The dysfunctional muscle-bone unit in juvenile idiopathic arthritis. J. Musculoskelet. Neuronal Interact. 6, 351–352 (2006)PubMed J.M. Burnham, J. Shults, H. Sembhi, B.S. Zemel, M.B. Leonard, The dysfunctional muscle-bone unit in juvenile idiopathic arthritis. J. Musculoskelet. Neuronal Interact. 6, 351–352 (2006)PubMed
68.
Zurück zum Zitat A. Tsampalieros, P. Gupta, M.R. Denburg, J. Shults, B.S. Zemel, S. Mostoufi-Moab, R.J. Wetzsteon, R.M. Herskovitz, K.M. Whitehead, M.B. Leonard, Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome. J. Bone Miner. Res. 28, 480–488 (2013)PubMed A. Tsampalieros, P. Gupta, M.R. Denburg, J. Shults, B.S. Zemel, S. Mostoufi-Moab, R.J. Wetzsteon, R.M. Herskovitz, K.M. Whitehead, M.B. Leonard, Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome. J. Bone Miner. Res. 28, 480–488 (2013)PubMed
69.
Zurück zum Zitat A. LeBlanc, R. Rowe, V. Schneider, H. Evans, T. Hedrick, Regional muscle loss after short duration spaceflight. Aviat. Space Environ. Med. 66, 1151–1154 (1995)PubMed A. LeBlanc, R. Rowe, V. Schneider, H. Evans, T. Hedrick, Regional muscle loss after short duration spaceflight. Aviat. Space Environ. Med. 66, 1151–1154 (1995)PubMed
70.
Zurück zum Zitat T. Trappe, Influence of aging and long-term unloading on the structure and function of human skeletal muscle. Appl. Physiol. Nutr. Metab. 34, 459–464 (2009)PubMedCentralPubMed T. Trappe, Influence of aging and long-term unloading on the structure and function of human skeletal muscle. Appl. Physiol. Nutr. Metab. 34, 459–464 (2009)PubMedCentralPubMed
71.
Zurück zum Zitat M.L. Bianchi, A. Mazzanti, E. Galbiati, S. Saraifoger, A. Dubini, F. Cornelio, L. Morandi, Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos. Int. 14, 761–767 (2003)PubMed M.L. Bianchi, A. Mazzanti, E. Galbiati, S. Saraifoger, A. Dubini, F. Cornelio, L. Morandi, Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos. Int. 14, 761–767 (2003)PubMed
72.
Zurück zum Zitat Y. Shirazi-Fard, J.S. Kupke, S.A. Bloomfield, H.A. Hogan, Discordant recovery of bone mass and mechanical properties during prolonged recovery from disuse. Bone 52, 433–443 (2013)PubMed Y. Shirazi-Fard, J.S. Kupke, S.A. Bloomfield, H.A. Hogan, Discordant recovery of bone mass and mechanical properties during prolonged recovery from disuse. Bone 52, 433–443 (2013)PubMed
73.
Zurück zum Zitat P. Szulc, S. Boutroy, S. Boutroy, N. Vilayphiou, M. Schoppet, M. Rauner, R. Chapurlat, C. Hamann, L.C. Hofbauer, Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study. J. Bone Miner. Res. 28(8), 1760–1770 (2013)PubMed P. Szulc, S. Boutroy, S. Boutroy, N. Vilayphiou, M. Schoppet, M. Rauner, R. Chapurlat, C. Hamann, L.C. Hofbauer, Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study. J. Bone Miner. Res. 28(8), 1760–1770 (2013)PubMed
74.
Zurück zum Zitat P. Szulc, S. Blaizot, S. Boutroy, N. Vilayphiou, S. Boonen, R. Chapurlat, Impaired bone microarchitecture at the distal radius in older men with low muscle mass and grip strength: the STRAMBO study. J. Bone Miner. Res. 28, 169–178 (2013)PubMed P. Szulc, S. Blaizot, S. Boutroy, N. Vilayphiou, S. Boonen, R. Chapurlat, Impaired bone microarchitecture at the distal radius in older men with low muscle mass and grip strength: the STRAMBO study. J. Bone Miner. Res. 28, 169–178 (2013)PubMed
75.
Zurück zum Zitat A. Sharir, T. Stern, C. Rot, R. Shahar, E. Zelzer, Muscle force regulates bone shaping for optimal load-bearing capacity during embryogenesis. Development 138, 3247–3259 (2011)PubMed A. Sharir, T. Stern, C. Rot, R. Shahar, E. Zelzer, Muscle force regulates bone shaping for optimal load-bearing capacity during embryogenesis. Development 138, 3247–3259 (2011)PubMed
76.
Zurück zum Zitat N.C. Nowlan, J. Sharpe, K.A. Roddy, P.J. Prendergast, P. Murphy, Mechanobiology of embryonic skeletal development: insights from animal models. Birth Defects Res. C 90, 203–213 (2010) N.C. Nowlan, J. Sharpe, K.A. Roddy, P.J. Prendergast, P. Murphy, Mechanobiology of embryonic skeletal development: insights from animal models. Birth Defects Res. C 90, 203–213 (2010)
77.
Zurück zum Zitat J. Kahn, Y. Shwartz, E. Blitz, S. Krief, A. Sharir, D.A. Breitel, R. Rattenbach, F. Relaix, P. Maire, R.B. Rountree, D.M. Kingsley, E. Zelzer, Muscle contraction is necessary to maintain joint progenitor cell fate. Dev. Cell 16, 734–743 (2009)PubMed J. Kahn, Y. Shwartz, E. Blitz, S. Krief, A. Sharir, D.A. Breitel, R. Rattenbach, F. Relaix, P. Maire, R.B. Rountree, D.M. Kingsley, E. Zelzer, Muscle contraction is necessary to maintain joint progenitor cell fate. Dev. Cell 16, 734–743 (2009)PubMed
78.
Zurück zum Zitat J.G. Hall, Analysis of Pena Shokeir phenotype. Am. J. Med. Genet. 25, 99–117 (1986)PubMed J.G. Hall, Analysis of Pena Shokeir phenotype. Am. J. Med. Genet. 25, 99–117 (1986)PubMed
79.
Zurück zum Zitat P. Juffer, R.T. Jaspers, P. Lips, A.D. Bakker, J. Klein-Nulend, Expression of muscle anabolic and metabolic factors in mechanically loaded MLO-Y4 osteocytes. Am. J. Physiol. Endocrinol. Metab. 302, E389–E395 (2012)PubMed P. Juffer, R.T. Jaspers, P. Lips, A.D. Bakker, J. Klein-Nulend, Expression of muscle anabolic and metabolic factors in mechanically loaded MLO-Y4 osteocytes. Am. J. Physiol. Endocrinol. Metab. 302, E389–E395 (2012)PubMed
80.
Zurück zum Zitat N.C. Nowlan, C. Bourdon, G. Dumas, S. Tajbakhsh, P.J. Prendergast, P. Murphy, Developing bones are differentially affected by compromised skeletal muscle formation. Bone 46, 1275–1285 (2010)PubMedCentralPubMed N.C. Nowlan, C. Bourdon, G. Dumas, S. Tajbakhsh, P.J. Prendergast, P. Murphy, Developing bones are differentially affected by compromised skeletal muscle formation. Bone 46, 1275–1285 (2010)PubMedCentralPubMed
81.
Zurück zum Zitat N.C. Nowlan, G. Dumas, S. Tajbakhsh, P.J. Prendergast, P. Murphy, Biophysical stimuli induced by passive movements compensate for lack of skeletal muscle during embryonic skeletogenesis. Biomech. Model. Mechanobiol. 11, 207–219 (2012)PubMed N.C. Nowlan, G. Dumas, S. Tajbakhsh, P.J. Prendergast, P. Murphy, Biophysical stimuli induced by passive movements compensate for lack of skeletal muscle during embryonic skeletogenesis. Biomech. Model. Mechanobiol. 11, 207–219 (2012)PubMed
82.
Zurück zum Zitat S.E. Warner, D.A. Sanford, B.A. Becker, S.D. Bain, S. Srinivasan, T.S. Gross, Botox induced muscle paralysis rapidly degrades bone. Bone 38, 257–264 (2006)PubMedCentralPubMed S.E. Warner, D.A. Sanford, B.A. Becker, S.D. Bain, S. Srinivasan, T.S. Gross, Botox induced muscle paralysis rapidly degrades bone. Bone 38, 257–264 (2006)PubMedCentralPubMed
83.
Zurück zum Zitat D. Joulia-Ekaza, G. Cabello, The myostatin gene: physiology and pharmacological relevance. Curr. Opin. Pharmacol. 7, 310–315 (2007)PubMed D. Joulia-Ekaza, G. Cabello, The myostatin gene: physiology and pharmacological relevance. Curr. Opin. Pharmacol. 7, 310–315 (2007)PubMed
84.
Zurück zum Zitat A.C. McPherron, A.M. Lawler, S.J. Lee, Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 83–90 (1997)PubMed A.C. McPherron, A.M. Lawler, S.J. Lee, Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 83–90 (1997)PubMed
85.
Zurück zum Zitat A.C. McPherron, S.J. Lee, Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl. Acad. Sci. USA 94, 12457–12461 (1997)PubMed A.C. McPherron, S.J. Lee, Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl. Acad. Sci. USA 94, 12457–12461 (1997)PubMed
86.
Zurück zum Zitat M. Schuelke, K.R. Wagner, L.E. Stolz, C. Hübner, T. Riebel, W. Kömen, T. Braun, J.F. Tobin, S.J. Lee, Myostatin mutation associated with gross muscle hypertrophy in a child. N. Engl. J. Med. 350, 2682–2688 (2004)PubMed M. Schuelke, K.R. Wagner, L.E. Stolz, C. Hübner, T. Riebel, W. Kömen, T. Braun, J.F. Tobin, S.J. Lee, Myostatin mutation associated with gross muscle hypertrophy in a child. N. Engl. J. Med. 350, 2682–2688 (2004)PubMed
87.
Zurück zum Zitat T.A. Zimmers, M.V. Davies, L.G. Koniaris, P. Haynes, A.F. Esquela, K.N. Tomkinson, A.C. McPherron, N.M. Wolfman, S.J. Lee, Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486–1488 (2002)PubMed T.A. Zimmers, M.V. Davies, L.G. Koniaris, P. Haynes, A.F. Esquela, K.N. Tomkinson, A.C. McPherron, N.M. Wolfman, S.J. Lee, Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486–1488 (2002)PubMed
88.
Zurück zum Zitat S. Reisz-Porszasz, S. Bhasin, J.N. Artaza, R. Shen, I. Sinha-Hikim, A. Hogue, T.J. Fielder, N.F. Gonzalez-Cadavid, Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am. J. Physiol. Endocrinol. Metab. 285, E876–E888 (2003)PubMed S. Reisz-Porszasz, S. Bhasin, J.N. Artaza, R. Shen, I. Sinha-Hikim, A. Hogue, T.J. Fielder, N.F. Gonzalez-Cadavid, Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am. J. Physiol. Endocrinol. Metab. 285, E876–E888 (2003)PubMed
89.
Zurück zum Zitat M.W. Hamrick, A.C. McPherron, C.O. Lovejoy, Bone mineral content and density in the humerus of myostatin-deficient mice. Calcif. Tissue Int. 71, 63–68 (2002)PubMed M.W. Hamrick, A.C. McPherron, C.O. Lovejoy, Bone mineral content and density in the humerus of myostatin-deficient mice. Calcif. Tissue Int. 71, 63–68 (2002)PubMed
90.
Zurück zum Zitat M.W. Hamrick, Increased bone mineral density in the femora of GDF8 knockout mice. Anat. Rec. 272, 388–391 (2003) M.W. Hamrick, Increased bone mineral density in the femora of GDF8 knockout mice. Anat. Rec. 272, 388–391 (2003)
91.
Zurück zum Zitat E. Montgomery, C. Pennington, M. Hamrick, Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice. Anat. Rec. 286, 814–822 (2005) E. Montgomery, C. Pennington, M. Hamrick, Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice. Anat. Rec. 286, 814–822 (2005)
92.
Zurück zum Zitat M.N. Elkasrawy, M.W. Hamrick, Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J. Musculoskelet. Neuronal Interact. 10, 56–63 (2010)PubMedCentralPubMed M.N. Elkasrawy, M.W. Hamrick, Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J. Musculoskelet. Neuronal Interact. 10, 56–63 (2010)PubMedCentralPubMed
93.
Zurück zum Zitat M.R. Morissette, J.C. Stricker, M.A. Rosenberg, C. Buranasombati, E.B. Levitan, M.A. Mittleman, A. Rosenzweig, Effects of myostatin deletion in aging mice. Aging Cell 8, 573–583 (2009)PubMedCentralPubMed M.R. Morissette, J.C. Stricker, M.A. Rosenberg, C. Buranasombati, E.B. Levitan, M.A. Mittleman, A. Rosenzweig, Effects of myostatin deletion in aging mice. Aging Cell 8, 573–583 (2009)PubMedCentralPubMed
94.
Zurück zum Zitat M.W. Hamrick, T. Samaddar, C. Pennington, J. McCormick, Increased muscle mass with myostatin deficiency improves gains in bone strength with exercise. J. Bone Miner. Res. 21, 477–483 (2006)PubMed M.W. Hamrick, T. Samaddar, C. Pennington, J. McCormick, Increased muscle mass with myostatin deficiency improves gains in bone strength with exercise. J. Bone Miner. Res. 21, 477–483 (2006)PubMed
95.
Zurück zum Zitat M.W. Hamrick, X. Shi, W. Zhang, C. Pennington, H. Thakore, M. Haque, B. Kang, C.M. Isales, S. Fulzele, K.H. Wenger, Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. Bone 40, 1544–1553 (2007)PubMedCentralPubMed M.W. Hamrick, X. Shi, W. Zhang, C. Pennington, H. Thakore, M. Haque, B. Kang, C.M. Isales, S. Fulzele, K.H. Wenger, Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. Bone 40, 1544–1553 (2007)PubMedCentralPubMed
96.
Zurück zum Zitat T. Guo, W. Jou, T. Chanturiya, J. Portas, O. Gavrilova, A.C. McPherron, Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 4, e4937 (2009)PubMedCentralPubMed T. Guo, W. Jou, T. Chanturiya, J. Portas, O. Gavrilova, A.C. McPherron, Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 4, e4937 (2009)PubMedCentralPubMed
97.
Zurück zum Zitat C. Zhang, C. McFarlane, S. Lokireddy, S. Masuda, X. Ge, P.D. Gluckman, M. Sharma, R. Kambadur, Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia 55, 183–193 (2012)PubMed C. Zhang, C. McFarlane, S. Lokireddy, S. Masuda, X. Ge, P.D. Gluckman, M. Sharma, R. Kambadur, Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia 55, 183–193 (2012)PubMed
98.
Zurück zum Zitat M. Elkasrawy, D. Immel, X. Wen, X. Liu, L.F. Liang, M.W. Hamrick, Immunolocalization of myostatin (GDF-8) following musculoskeletal injury and the effects of exogenous myostatin on muscle and bone healing. J. Histochem. Cytochem. 60, 22–30 (2012)PubMed M. Elkasrawy, D. Immel, X. Wen, X. Liu, L.F. Liang, M.W. Hamrick, Immunolocalization of myostatin (GDF-8) following musculoskeletal injury and the effects of exogenous myostatin on muscle and bone healing. J. Histochem. Cytochem. 60, 22–30 (2012)PubMed
99.
Zurück zum Zitat S. Lokireddy, I.W. Wijesoma, S. Bonala, M. Wei, S.K. Sze, C. McFarlane, R. Kambadur, M. Sharma, Myostatin is a novel tumoral factor that induces cancer cachexia. Biochem. J. 446, 23–36 (2012)PubMedCentralPubMed S. Lokireddy, I.W. Wijesoma, S. Bonala, M. Wei, S.K. Sze, C. McFarlane, R. Kambadur, M. Sharma, Myostatin is a novel tumoral factor that induces cancer cachexia. Biochem. J. 446, 23–36 (2012)PubMedCentralPubMed
100.
Zurück zum Zitat Z.L. Zhang, J.W. He, Y.J. Qin, Y.Q. Hu, M. Li, H. Zhang, W.W. Hu, Y.J. Liu, J.M. Gu, Association between myostatin gene polymorphisms and peak BMD variation in Chinese nuclear families. Osteoporos. Int. 19, 39–47 (2008)PubMed Z.L. Zhang, J.W. He, Y.J. Qin, Y.Q. Hu, M. Li, H. Zhang, W.W. Hu, Y.J. Liu, J.M. Gu, Association between myostatin gene polymorphisms and peak BMD variation in Chinese nuclear families. Osteoporos. Int. 19, 39–47 (2008)PubMed
101.
Zurück zum Zitat K.M. Lakshman, S. Bhasin, C. Corcoran, L.A. Collins-Racie, L. Tchistiakova, S.B. Forlow, K. St Ledger, M.E. Burczynski, A.J. Dorner, E.R. Lavallie, Measurement of myostatin concentrations in human serum: circulating concentrations in young and older men and effects of testosterone administration. Mol. Cell. Endocrinol. 302, 26–32 (2009)PubMed K.M. Lakshman, S. Bhasin, C. Corcoran, L.A. Collins-Racie, L. Tchistiakova, S.B. Forlow, K. St Ledger, M.E. Burczynski, A.J. Dorner, E.R. Lavallie, Measurement of myostatin concentrations in human serum: circulating concentrations in young and older men and effects of testosterone administration. Mol. Cell. Endocrinol. 302, 26–32 (2009)PubMed
102.
Zurück zum Zitat P. Szulc, M. Schoppet, C. Goettsch, M. Rauner, T. Dschietzig, R. Chapurlat, L.C. Hofbauer, Endocrine and clinical correlates of myostatin serum concentration in men–the STRAMBO study. J. Clin. Endocrinol. Metab. 97, 3700–3708 (2012)PubMed P. Szulc, M. Schoppet, C. Goettsch, M. Rauner, T. Dschietzig, R. Chapurlat, L.C. Hofbauer, Endocrine and clinical correlates of myostatin serum concentration in men–the STRAMBO study. J. Clin. Endocrinol. Metab. 97, 3700–3708 (2012)PubMed
104.
Zurück zum Zitat R.A. Brekken, E.H. Sage, SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 19, 816–827 (2001)PubMed R.A. Brekken, E.H. Sage, SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 19, 816–827 (2001)PubMed
105.
Zurück zum Zitat L.H. Jorgensen, S.J. Petersson, J. Sellathurai, D.C. Andersen, S. Thayssen, D.J. Sant, C.H. Jensen, H.D. Schrøder, Secreted protein acidic and rich in cysteine (SPARC) in human skeletal muscle. J. Histochem. Cytochem. 57, 29–39 (2009)PubMed L.H. Jorgensen, S.J. Petersson, J. Sellathurai, D.C. Andersen, S. Thayssen, D.J. Sant, C.H. Jensen, H.D. Schrøder, Secreted protein acidic and rich in cysteine (SPARC) in human skeletal muscle. J. Histochem. Cytochem. 57, 29–39 (2009)PubMed
106.
Zurück zum Zitat B.R. Barnes, E.R. Szelenyi, G.L. Warren, M.L. Urso, Alterations in mRNA and protein levels of metalloproteinases-2, -9, and -14 and tissue inhibitor of metalloproteinase-2 in responses to traumatic skeletal muscle injury. Am. J. Physiol. Cell Physiol. 297, C1501–C1508 (2009)PubMed B.R. Barnes, E.R. Szelenyi, G.L. Warren, M.L. Urso, Alterations in mRNA and protein levels of metalloproteinases-2, -9, and -14 and tissue inhibitor of metalloproteinase-2 in responses to traumatic skeletal muscle injury. Am. J. Physiol. Cell Physiol. 297, C1501–C1508 (2009)PubMed
107.
Zurück zum Zitat L.S. Quinn, B.G. Anderson, L. Strait-Bodey, A. Stroud, J. Argiles, Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am. J. Physiol. Endocrinol. Metab. 296, E191–E202 (2009)PubMed L.S. Quinn, B.G. Anderson, L. Strait-Bodey, A. Stroud, J. Argiles, Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am. J. Physiol. Endocrinol. Metab. 296, E191–E202 (2009)PubMed
108.
Zurück zum Zitat B.K. Pedersen, F. Edward, Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J. Appl. Physiol. 107, 1006–1014 (2009)PubMed B.K. Pedersen, F. Edward, Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J. Appl. Physiol. 107, 1006–1014 (2009)PubMed
109.
Zurück zum Zitat M.N. Weitzmann, C. Roggia, G. Toraldo, L. Weitzmann, R. Pacifici, Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J. Clin. Invest. 110, 1643–1650 (2002)PubMedCentralPubMed M.N. Weitzmann, C. Roggia, G. Toraldo, L. Weitzmann, R. Pacifici, Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J. Clin. Invest. 110, 1643–1650 (2002)PubMedCentralPubMed
110.
Zurück zum Zitat W.M. Jackson, A.B. Aragon, J. Onodera, S.M. Koehler, Y. Ji, J.D. Bulken-Hoover, J.A. Vogler, R.S. Tuan, L.J. Nesti, Cytokine expression in muscle following traumatic injury. J. Orthop. Res. 29, 1613–1620 (2011)PubMedCentralPubMed W.M. Jackson, A.B. Aragon, J. Onodera, S.M. Koehler, Y. Ji, J.D. Bulken-Hoover, J.A. Vogler, R.S. Tuan, L.J. Nesti, Cytokine expression in muscle following traumatic injury. J. Orthop. Res. 29, 1613–1620 (2011)PubMedCentralPubMed
111.
Zurück zum Zitat K. Tanaka, E. Matsumoto, Y. Higashimaki, T. Katagiri, T. Sugimoto, S. Seino, H. Kaji, Role of osteoglycin in the linkage between muscle and bone. J. Biol. Chem. 287, 11616–11628 (2012)PubMed K. Tanaka, E. Matsumoto, Y. Higashimaki, T. Katagiri, T. Sugimoto, S. Seino, H. Kaji, Role of osteoglycin in the linkage between muscle and bone. J. Biol. Chem. 287, 11616–11628 (2012)PubMed
112.
Zurück zum Zitat K. Tanaka, E. Matsumoto, Y. Higashimaki, T. Sugimoto, S. Seino, H. Kaji, FAM5C is a soluble osteoblast differentiation factor linking muscle to bone. Biochem. Biophys. Res. Commun. 418, 134–139 (2012)PubMed K. Tanaka, E. Matsumoto, Y. Higashimaki, T. Sugimoto, S. Seino, H. Kaji, FAM5C is a soluble osteoblast differentiation factor linking muscle to bone. Biochem. Biophys. Res. Commun. 418, 134–139 (2012)PubMed
113.
Zurück zum Zitat M.W. Hamrick, P.L. McNeil, S.L. Patterson, Role of muscle-derived growth factors in bone formation. J. Musculoskelet. Neuronal Interact. 10, 64–70 (2010)PubMedCentralPubMed M.W. Hamrick, P.L. McNeil, S.L. Patterson, Role of muscle-derived growth factors in bone formation. J. Musculoskelet. Neuronal Interact. 10, 64–70 (2010)PubMedCentralPubMed
114.
Zurück zum Zitat K. Jähn, N. Lara-Castillo, L. Brotto, C.L. Mo, M.L. Johnson, M. Brotto, L.F. Bonewald, Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of β-catenin. Eur. Cell Mater. 24, 197–209 (2012). Discussion 209–210PubMedCentralPubMed K. Jähn, N. Lara-Castillo, L. Brotto, C.L. Mo, M.L. Johnson, M. Brotto, L.F. Bonewald, Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of β-catenin. Eur. Cell Mater. 24, 197–209 (2012). Discussion 209–210PubMedCentralPubMed
116.
Zurück zum Zitat C. Mo, S. Romero-Suarez, L. Bonewald, M. Johnson, M. Brotto, Prostaglandin e2: from clinical applications to its potential role in bone- muscle crosstalk and myogenic differentiation. Recent Pat. Biotechnol. 6, 223–229 (2012)PubMedCentralPubMed C. Mo, S. Romero-Suarez, L. Bonewald, M. Johnson, M. Brotto, Prostaglandin e2: from clinical applications to its potential role in bone- muscle crosstalk and myogenic differentiation. Recent Pat. Biotechnol. 6, 223–229 (2012)PubMedCentralPubMed
118.
Zurück zum Zitat S.I. Zacks, M.F. Sheff, Periosteal and metaplastic bone formation in mouse minced muscle regeneration. Lab. Invest. 46, 405–412 (1982)PubMed S.I. Zacks, M.F. Sheff, Periosteal and metaplastic bone formation in mouse minced muscle regeneration. Lab. Invest. 46, 405–412 (1982)PubMed
119.
Zurück zum Zitat P.S. Landry, A. Marino, K. Sadasivan, A. Albright, Effect of soft-tissue trauma on the early periosteal response of bone to injury. J. Trauma 48, 479–483 (2000)PubMed P.S. Landry, A. Marino, K. Sadasivan, A. Albright, Effect of soft-tissue trauma on the early periosteal response of bone to injury. J. Trauma 48, 479–483 (2000)PubMed
120.
Zurück zum Zitat S.E. Utvag, K.B. Iversen, O. Grundnes, O. Reikeras, Poor muscle coverage delays fracture healing in rats. Acta Orthop Scand. 73, 471–474 (2002)PubMed S.E. Utvag, K.B. Iversen, O. Grundnes, O. Reikeras, Poor muscle coverage delays fracture healing in rats. Acta Orthop Scand. 73, 471–474 (2002)PubMed
121.
Zurück zum Zitat H. Stein, S.M. Perren, J. Cordey, J. Kenwright, R. Mosheiff, M.J. Francis, The muscle bed–a crucial factor for fracture healing: a physiological concept. Orthopedics 25, 1379–1383 (2002)PubMed H. Stein, S.M. Perren, J. Cordey, J. Kenwright, R. Mosheiff, M.J. Francis, The muscle bed–a crucial factor for fracture healing: a physiological concept. Orthopedics 25, 1379–1383 (2002)PubMed
122.
Zurück zum Zitat M.M. Reverte, R. Dimitriou, N.K. Kanakaris, P.V. Giannoudis, What is the effect of compartment syndrome and fasciotomies on fracture healing in tibial fractures? Injury 42, 1402–1407 (2011)PubMed M.M. Reverte, R. Dimitriou, N.K. Kanakaris, P.V. Giannoudis, What is the effect of compartment syndrome and fasciotomies on fracture healing in tibial fractures? Injury 42, 1402–1407 (2011)PubMed
123.
Zurück zum Zitat L.E. Harry, A. Sandison, E.M. Paleolog, U. Hansen, M.F. Pearse, J. Nanchahal, Comparison of the healing of open tibial fractures covered with either muscle or fasciocutaneous tissue in a murine model. J. Orthop. Res. 26, 1238–1244 (2008)PubMed L.E. Harry, A. Sandison, E.M. Paleolog, U. Hansen, M.F. Pearse, J. Nanchahal, Comparison of the healing of open tibial fractures covered with either muscle or fasciocutaneous tissue in a murine model. J. Orthop. Res. 26, 1238–1244 (2008)PubMed
124.
Zurück zum Zitat S. Gopal, S. Majumder, A.G. Batchelor, S.L. Knight, S.L. Knight, P. De Boer, R.M. Smith, Fix and flap: the radical orthopaedic and plastic treatment of severe open fractures of the tibia. J. Bone Joint Surg. Br. 82, 959–966 (2000)PubMed S. Gopal, S. Majumder, A.G. Batchelor, S.L. Knight, S.L. Knight, P. De Boer, R.M. Smith, Fix and flap: the radical orthopaedic and plastic treatment of severe open fractures of the tibia. J. Bone Joint Surg. Br. 82, 959–966 (2000)PubMed
125.
Zurück zum Zitat A. Schindeler, R. Liu, D.G. Little, The contribution of different cell lineages to bone repair: exploring a role for muscle stem cells. Differentiation 77, 12–18 (2009)PubMed A. Schindeler, R. Liu, D.G. Little, The contribution of different cell lineages to bone repair: exploring a role for muscle stem cells. Differentiation 77, 12–18 (2009)PubMed
126.
Zurück zum Zitat R. Liu, A. Schindeler, D.G. Little, The potential role of muscle in bone repair. J. Musculoskelet. Neuronal Interact. 10, 71–76 (2010)PubMed R. Liu, A. Schindeler, D.G. Little, The potential role of muscle in bone repair. J. Musculoskelet. Neuronal Interact. 10, 71–76 (2010)PubMed
127.
Zurück zum Zitat G.E. Glass, J.K. Chan, A. Freidin, M. Feldmann, N.J. Horwood, J. Nanchahal, TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc. Natl. Acad. Sci. U S A 108, 1585–1590 (2011)PubMedCentralPubMed G.E. Glass, J.K. Chan, A. Freidin, M. Feldmann, N.J. Horwood, J. Nanchahal, TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc. Natl. Acad. Sci. U S A 108, 1585–1590 (2011)PubMedCentralPubMed
128.
Zurück zum Zitat D.M. Cairns, P. Lee, T. Uchimura, C.R. Seufert, H. Kwon, L. Zeng, The role of muscle cells in regulating cartilage matrix production. J. Orthop. Res. 28, 529–536 (2010)PubMedCentralPubMed D.M. Cairns, P. Lee, T. Uchimura, C.R. Seufert, H. Kwon, L. Zeng, The role of muscle cells in regulating cartilage matrix production. J. Orthop. Res. 28, 529–536 (2010)PubMedCentralPubMed
129.
Zurück zum Zitat G. Duda, W. Taylor, T. Winkler, G. Matziolis, M. Heller, N. Haas, C. Perka, K.D. Schaser, Biomechanical, microvascular, and cellular factors promote muscle and bone re generation. Exerc. Sports Sci. Rev. 36, 64–70 (2008) G. Duda, W. Taylor, T. Winkler, G. Matziolis, M. Heller, N. Haas, C. Perka, K.D. Schaser, Biomechanical, microvascular, and cellular factors promote muscle and bone re generation. Exerc. Sports Sci. Rev. 36, 64–70 (2008)
130.
Zurück zum Zitat Y. Hao, Y. Ma, X. Wang, F. Jin, S. Ge, Short-term muscle atrophy caused by botulinum toxin-A local injection impairs fracture healing in the rat femur. J. Orthop. Res. 30, 574–580 (2012)PubMed Y. Hao, Y. Ma, X. Wang, F. Jin, S. Ge, Short-term muscle atrophy caused by botulinum toxin-A local injection impairs fracture healing in the rat femur. J. Orthop. Res. 30, 574–580 (2012)PubMed
131.
Zurück zum Zitat E. Kellum, H. Starr, P. Arounleut, D. Immel, S. Fulzele, K. Wenger, M.W. Hamrick, Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression and callus bone volume. Bone 44, 17–23 (2009)PubMedCentralPubMed E. Kellum, H. Starr, P. Arounleut, D. Immel, S. Fulzele, K. Wenger, M.W. Hamrick, Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression and callus bone volume. Bone 44, 17–23 (2009)PubMedCentralPubMed
132.
Zurück zum Zitat M.W. Hamrick, P. Arounleut, E. Kellum, M. Cain, D. Immel, L.F. Liang, Recombinant myostatin (GDF-8) propeptide enhances the repair and regeneration of both muscle and bone in a model of deep penetrant musculoskeletal injury. J. Trauma 69, 579–583 (2010)PubMedCentralPubMed M.W. Hamrick, P. Arounleut, E. Kellum, M. Cain, D. Immel, L.F. Liang, Recombinant myostatin (GDF-8) propeptide enhances the repair and regeneration of both muscle and bone in a model of deep penetrant musculoskeletal injury. J. Trauma 69, 579–583 (2010)PubMedCentralPubMed
133.
Zurück zum Zitat L.D. Gillespie, M.C. Robertson, W.J. Gillespie, C. Sherrington, S. Gates, L.M. Clemson, S.E. Lamb, Interventions for preventing falls in older people living in the community. Cochrane Database Syst. Rev. 9, 007146 (2012) L.D. Gillespie, M.C. Robertson, W.J. Gillespie, C. Sherrington, S. Gates, L.M. Clemson, S.E. Lamb, Interventions for preventing falls in older people living in the community. Cochrane Database Syst. Rev. 9, 007146 (2012)
134.
Zurück zum Zitat A. Mithal, J.P. Bonjour, S. Boonen, P. Burckhardt, H. Degens, G. El Hajj Fuleihan, R. Josse, P. Lips, J. Morales Torres, R. Rizzoli, N. Yoshimura, D.A. Wahl, C. Cooper, B. Dawson-Hughes, IOF CSA Nutrition Working Group, Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos. Int. 24(5), 1555 (2012)PubMed A. Mithal, J.P. Bonjour, S. Boonen, P. Burckhardt, H. Degens, G. El Hajj Fuleihan, R. Josse, P. Lips, J. Morales Torres, R. Rizzoli, N. Yoshimura, D.A. Wahl, C. Cooper, B. Dawson-Hughes, IOF CSA Nutrition Working Group, Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos. Int. 24(5), 1555 (2012)PubMed
135.
Zurück zum Zitat J. Rittweger, Vibration as an exercise modality: how it may work, and what its potential might be. Eur. J. Appl. Physiol. 108, 877–904 (2010)PubMed J. Rittweger, Vibration as an exercise modality: how it may work, and what its potential might be. Eur. J. Appl. Physiol. 108, 877–904 (2010)PubMed
136.
Zurück zum Zitat J. Rittweger, G. Beller, G. Armbrecht, E. Mulder, B. Buehring, U. Gast, F. Dimeo, H. Schubert, A. de Haan, D.F. Stegeman, H. Schiessl, D. Felsenberg, Prevention of bone loss during 56 days of strict bed rest by side-alternating resistive vibration exercise. Bone 46, 137–147 (2010)PubMed J. Rittweger, G. Beller, G. Armbrecht, E. Mulder, B. Buehring, U. Gast, F. Dimeo, H. Schubert, A. de Haan, D.F. Stegeman, H. Schiessl, D. Felsenberg, Prevention of bone loss during 56 days of strict bed rest by side-alternating resistive vibration exercise. Bone 46, 137–147 (2010)PubMed
137.
Zurück zum Zitat M.E. Chan, G. Uzer, C.T. Rubin, The potential benefits and inherent risks of vibration as a non-drug therapy for the prevention and treatment of osteoporosis. Curr. Osteoporos. Rep. 11, 36–44 (2013)PubMed M.E. Chan, G. Uzer, C.T. Rubin, The potential benefits and inherent risks of vibration as a non-drug therapy for the prevention and treatment of osteoporosis. Curr. Osteoporos. Rep. 11, 36–44 (2013)PubMed
138.
Zurück zum Zitat M.W. Hamrick, Myostatin (GDF-8) as a Therapeutic Target for the Prevention of Osteoporotic Fractures. IBMS BoneKEy. 7, 8–17 (2010). doi:10.1138/20100423 M.W. Hamrick, Myostatin (GDF-8) as a Therapeutic Target for the Prevention of Osteoporotic Fractures. IBMS BoneKEy. 7, 8–17 (2010). doi:10.​1138/​20100423
139.
Zurück zum Zitat K. Tsuchida, M. Nakatani, K. Hitachi, A. Uezumi, Y. Sunada, H. Ageta, K. Inokuchi, Activin signaling as an emerging target for therapeutic interventions. Cell. Commun. Signal. 7, 15–19 (2009)PubMedCentralPubMed K. Tsuchida, M. Nakatani, K. Hitachi, A. Uezumi, Y. Sunada, H. Ageta, K. Inokuchi, Activin signaling as an emerging target for therapeutic interventions. Cell. Commun. Signal. 7, 15–19 (2009)PubMedCentralPubMed
140.
Zurück zum Zitat A.D. Mitchell, R.J. Wall, In vivo evaluation of changes in body composition of transgenic mice expressing the myostatin pro domain using dual energy X-ray absorptiometry. Growth Dev. Aging 70, 25–37 (2007)PubMed A.D. Mitchell, R.J. Wall, In vivo evaluation of changes in body composition of transgenic mice expressing the myostatin pro domain using dual energy X-ray absorptiometry. Growth Dev. Aging 70, 25–37 (2007)PubMed
141.
Zurück zum Zitat S.J. Lee, L.A. Reed, M.V. Davies, S. Girgenrath, M.E. Goad, K.N. Tomkinson, J.F. Wright, C. Barker, G. Ehrmantraut, J. Holmstrom, B. Trowell, B. Gertz, M.S. Jiang, S.M. Sebald, M. Matzuk, E. Li, L.F. Liang, E. Quattlebaum, R.L. Stotish, N.M. Wolfman, Regulation of muscle growth by multiple ligands signalling through activin type II receptors. Proc. Natl. Acad. Sci. U S A 102, 18117–18122 (2005)PubMedCentralPubMed S.J. Lee, L.A. Reed, M.V. Davies, S. Girgenrath, M.E. Goad, K.N. Tomkinson, J.F. Wright, C. Barker, G. Ehrmantraut, J. Holmstrom, B. Trowell, B. Gertz, M.S. Jiang, S.M. Sebald, M. Matzuk, E. Li, L.F. Liang, E. Quattlebaum, R.L. Stotish, N.M. Wolfman, Regulation of muscle growth by multiple ligands signalling through activin type II receptors. Proc. Natl. Acad. Sci. U S A 102, 18117–18122 (2005)PubMedCentralPubMed
142.
Zurück zum Zitat S. Bogdanovich, T.O. Krag, E.R. Barton, L.D. Morris, L.A. Whittemore, R.S. Ahima, T.S. Khurana, Functional improvement of dystrophic muscle by myostatin blockade. Nature 420, 418–421 (2002)PubMed S. Bogdanovich, T.O. Krag, E.R. Barton, L.D. Morris, L.A. Whittemore, R.S. Ahima, T.S. Khurana, Functional improvement of dystrophic muscle by myostatin blockade. Nature 420, 418–421 (2002)PubMed
143.
Zurück zum Zitat K.R. Wagner, J.L. Fleckenstein, A.A. Amato, R.J. Barohn, K. Bushby, D.M. Escolar, K.M. Flanigan, A. Pestronk, R. Tawil, G.I. Wolfe, M. Eagle, J.M. Florence, W.M. King, S. Pandya, V. Straub, P. Juneau, K. Meyers, C. Csimma, T. Araujo, R. Allen, S.A. Parsons, J.M. Wozney, E.R. Lavallie, J.R. Mendell, A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy. Ann. Neurol. 63, 561–571 (2008)PubMed K.R. Wagner, J.L. Fleckenstein, A.A. Amato, R.J. Barohn, K. Bushby, D.M. Escolar, K.M. Flanigan, A. Pestronk, R. Tawil, G.I. Wolfe, M. Eagle, J.M. Florence, W.M. King, S. Pandya, V. Straub, P. Juneau, K. Meyers, C. Csimma, T. Araujo, R. Allen, S.A. Parsons, J.M. Wozney, E.R. Lavallie, J.R. Mendell, A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy. Ann. Neurol. 63, 561–571 (2008)PubMed
144.
Zurück zum Zitat N.K. LeBrasseur, T.M. Schelhorn, B.L. Bernardo, P.G. Cosgrove, P.M. Loria, T.A. Brown, Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice. J. Gerontol. A 64, 940–948 (2009) N.K. LeBrasseur, T.M. Schelhorn, B.L. Bernardo, P.G. Cosgrove, P.M. Loria, T.A. Brown, Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice. J. Gerontol. A 64, 940–948 (2009)
145.
Zurück zum Zitat P. Bialek, J. Parkington, L. Warner, M. St. Andre, L. Jian, D. Gavin, C. Wallace, J. Zhang, G. Yan, A. Root, H. Seeherman, P. Yaworsky, Mice treated with a myostatin/GDF-8 decoy receptor, ActRIIB-Fc, exhibit a tremendous increase in bone mass. Bone 42(Suppl 1), S46 (2008) P. Bialek, J. Parkington, L. Warner, M. St. Andre, L. Jian, D. Gavin, C. Wallace, J. Zhang, G. Yan, A. Root, H. Seeherman, P. Yaworsky, Mice treated with a myostatin/GDF-8 decoy receptor, ActRIIB-Fc, exhibit a tremendous increase in bone mass. Bone 42(Suppl 1), S46 (2008)
146.
Zurück zum Zitat V. Ferguson, R. Paietta, L. Stodieck, A. Hanson, M. Young, T. Bateman, M. Lemus, P. Kostenuik, E. Jiao, X. Zhou, J. Lu, W. Simonet, D. Lacey, H. Han, Inhibiting myostatin prevents microgravity-associated bone loss in mice. J. Bone Miner. Res. 24(Suppl 1), 1288 (2009) V. Ferguson, R. Paietta, L. Stodieck, A. Hanson, M. Young, T. Bateman, M. Lemus, P. Kostenuik, E. Jiao, X. Zhou, J. Lu, W. Simonet, D. Lacey, H. Han, Inhibiting myostatin prevents microgravity-associated bone loss in mice. J. Bone Miner. Res. 24(Suppl 1), 1288 (2009)
147.
Zurück zum Zitat K.M. Attie, N.G. Borgstein, Y. Yang, C.H. Condon, D.M. Wilson, A.E. Pearsall, R. Kumar, D.A. Willins, J.S. Seehra, M.L. Sherman, A single ascending-dose study of muscle regulator ace-031 in healthy volunteers. Muscle Nerve 47, 416–423 (2013)PubMed K.M. Attie, N.G. Borgstein, Y. Yang, C.H. Condon, D.M. Wilson, A.E. Pearsall, R. Kumar, D.A. Willins, J.S. Seehra, M.L. Sherman, A single ascending-dose study of muscle regulator ace-031 in healthy volunteers. Muscle Nerve 47, 416–423 (2013)PubMed
148.
Zurück zum Zitat O. Guardiola, P. Lafuste, S. Brunelli, S. Iaconis, T. Touvier, P. Mourikis, K. De Bock, E. Lonardo, G. Andolfi, A. Bouché, G.L. Liguori, M.M. Shen, S. Tajbakhsh, G. Cossu, P. Carmeliet, G. Minchiotti, Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myostatin. Proc. Natl. Acad. Sci. U S A 109, E3231–E3240 (2012)PubMedCentralPubMed O. Guardiola, P. Lafuste, S. Brunelli, S. Iaconis, T. Touvier, P. Mourikis, K. De Bock, E. Lonardo, G. Andolfi, A. Bouché, G.L. Liguori, M.M. Shen, S. Tajbakhsh, G. Cossu, P. Carmeliet, G. Minchiotti, Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myostatin. Proc. Natl. Acad. Sci. U S A 109, E3231–E3240 (2012)PubMedCentralPubMed
149.
Zurück zum Zitat H. Yamamoto, E.G. Williams, L. Mouchiroud, C. Cantó, W. Fan, M. Downes, C. Héligon, G.D. Barish, B. Desvergne, R.M. Evans, K. Schoonjans, J. Auwerx, NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell 147, 827–839 (2011)PubMedCentralPubMed H. Yamamoto, E.G. Williams, L. Mouchiroud, C. Cantó, W. Fan, M. Downes, C. Héligon, G.D. Barish, B. Desvergne, R.M. Evans, K. Schoonjans, J. Auwerx, NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell 147, 827–839 (2011)PubMedCentralPubMed
Metadaten
Titel
Muscle–bone interactions: basic and clinical aspects
Publikationsdatum
01.03.2014
Erschienen in
Endocrine / Ausgabe 2/2014
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0026-8

Weitere Artikel der Ausgabe 2/2014

Endocrine 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.